VBIV - VBI Vaccines, Inc. Year-over-year net earnings per share growth for the last 12 months

Official company branding of VBI Vaccines Inc. (VBIV)

Quarterly EPS progress demonstrates the profit dynamics of VBI Vaccines Inc. (VBIV), where the 0.00 mark reflects the latest data. This chart captures a technical pause resulting from financial restructuring and an R&D freeze. VBI Vaccines Inc. (VBIV) generates revenue through the sale of its Hepatitis B vaccine and partnership grants. The potential for share price growth now relies on the success of its glioblastoma therapy and new contracts.

VBI Vaccines, Inc. (VBIV) Year-over-year net earnings per share change for the last twelve months: for the period 07/04/2022 - 08/17/2024

Financial and market metric breakdowns for vbivaccines.com (VBIV)

- market value and analyst target forecast:
- market capitalization statistics:
Analysis of all company metrics:vbivaccines.com, VBIV
Flagship merchandise of VBI Vaccines Inc.

The strong pricing power of VBI Vaccines Inc. (VBIV), driven by the uniqueness of its eVLP platform, should translate into growth in net earnings per share. By analyzing the quarterly shift in earnings per share, an investor assesses the EPS trend relative to the previous period, which allows for the mathematical confirmation of innovation monetization efficiency and prevents capital from being frozen in an overvalued asset.

Who VBI Vaccines Inc. competes with

Gilead Sciences Inc (GILD) - Year-over-year earnings per share growth for the last twelve months|Cidara - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months NVAX|Quarterly EPS earnings growth curevac.com|Year-over-year earnings per share growth for the last twelve months Valneva Corp (VALN)|Year-over-year earnings per share growth for the last twelve months VIR (Vir Biotechnology)|Year-over-year earnings per share growth for the last twelve months TPOXX SIGA|EBS - Year-over-year net earnings per share growth for the last 12 months|AVIR: Year-over-year net earnings per share growth for the last 12 months|IVVD (Invivyd Inc) - Year-over-year earnings per share growth for the last 12 months|ENTA: Quarterly EPS earnings growth|INO (Inovio) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months HilleVax Corp|Quarterly EPS earnings growth Kalaris Tx|Quarterly EPS earnings growth DYAI|Year-over-year earnings per share growth for the last twelve months NNVC (NanoViricides)|Quarterly EPS earnings growth TLPH (Talphera Corporation)|Year-over-year net earnings per share change for the last twelve months Cocrystal (COCP)|TRAW - Year-over-year earnings per share growth for the last twelve months|DWTX (Dogwood Therapeutics Inc.) - Year-over-year earnings per share growth for the last 12 months|Qualigen Therapeutics, Inc. (QLGN) - Year-over-year earnings per share growth for the last twelve months|AlloVir Inc - Year-over-year earnings per one share growth for the last 12 months|VIRI (virios.com) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months VXRT (Vaxart, Inc.)